We are live on ! Find out more

Steris

STE

Market cap $20.8B

213.66 USD

+2.90

1.38%

At close Updated Sep 14, 4:00 PM EDT

Pre-market

After hours

213.66

0.00

0%

1 day

1.38%

5 days

-3.73%

1 month

-8.41%

3 months

3.75%

6 months

-2.46%

Year to date

-14.55%

1 year

-13.78%

5 years

-1.06%

10 years

205.23%

About: Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Employees: 17,937

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 44.4%

Neutral 50%

Negative 5.6%

Zacks Investment Research

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?

Steris (STE) reported earnings 30 days ago. What's next for the stock?

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?

STERIS to Present at the Morgan Stanley Healthcare Conference

Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.

STERIS to Present at the Morgan Stanley Healthcare Conference

Zacks Investment Research

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

Zacks Investment Research

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

STERIS Q1 Earnings Call Highlights

STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.

STERIS Q1 Earnings Call Highlights

STERIS plc (STE) Q1 2027 Earnings Call Transcript

STERIS plc (STE) Q1 2027 Earnings Call Transcript

STERIS plc (STE) Q1 2027 Earnings Call Transcript

Zacks Investment Research

STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading

STERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.

STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading

Zacks Investment Research

5 Quality Stocks Set to Reward Investors With Dividend Hikes

Recent dividend hikes from DRH, STE, BCC, KWR and WHD highlight financially solid companies as investors seek stability in a mixed market.

5 Quality Stocks Set to Reward Investors With Dividend Hikes

Zacks Investment Research

Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings

While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings

Zacks Investment Research

Steris (STE) Q1 Earnings Surpass Estimates

Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago.

Steris (STE) Q1 Earnings Surpass Estimates

See News Rankings

Price charts implemented using Lightweight Charts™